Post #4 answers the question as asked. The question underneath it is different. I would be cautious about generalising from the taste changes and food aversion example above. It is a good example. It is one example.
Posting this under the heading it deserves: Taste changes and food aversion, reported and discussed Everything below is what sits behind that.
The question about taste changes and food aversion that I actually want answered is the second one below. The first is context and I have kept it short.
Both are stated with units, and I have said what I already checked so that nobody repeats it.
Worth separating two things that the opening post runs together.
Practical experience of taste changes and food aversion, offered as one case with the conditions stated, not as a general finding. Conditions first, because they are what make it interpretable.
The opening post is right about the mechanism and I think understates the practical bit.
Hair shedding: telogen effluvium associated with rapid weight loss is reported. The timing usually correlates with the speed of weight change rather than the compound specifically. It is usually self-limiting.
The general answer and the answer for your case may diverge here.
The published rates come from populations that were titrated on a defined schedule with clinical supervision. Rates from a forum are not comparable and are biased by who chooses to post.
I have no interest in any supplier named above.
Post #4 answers the question as asked. The question underneath it is different.
I would be cautious about generalising from the taste changes and food aversion example above. It is a good example. It is one example.
I read post #6 twice before replying, because I had assumed the opposite.
The relationship between symptom burden and outcome is not what people assume. Feeling worse is not evidence of a larger effect and feeling nothing is not evidence of an inactive preparation.
Building on post #8 rather than restating it.
The published rates come from populations that were titrated on a defined schedule with clinical supervision. Rates from a forum are not comparable and are biased by who chooses to post.
The short version is the first sentence; the rest is why.
Injection site reaction: local erythema, nodules, or induration at injection sites is reported by some people. Site rotation, avoiding reinjection into the same area for weeks, and allowing areas that react to recover all reduce the frequency.
The uncertainty is in the assumption, not in the calculation.
Coming back to post #9, because the follow-up matters more than the original answer.
Practical note on taste changes and food aversion: write down what you expect before you look. The number of times I have found what I went looking for is higher than chance would allow.
I disagree with the framing of taste changes and food aversion above, and I think it is a substantive disagreement rather than a terminological one. Setting out why, so it can be checked.
The reasoning depends on an assumption that is doing a lot of work and is never stated. If the assumption holds, the conclusion follows. I do not think it holds generally.
Constipation is reported at least as often as nausea and is discussed a fraction as much. Fluid, fibre and movement are the boring answers and they are the ones that work.
I read post #13 twice before replying, because I had assumed the opposite.
Two things can be true about taste changes and food aversion at once: the mechanism is plausible and the evidence for the size of the effect is thin. Most of the argument here is people defending the first against attacks on the second.
Post #13 answers the question as asked. The question underneath it is different.
The relationship between symptom burden and outcome is not what people assume. Feeling worse is not evidence of a larger effect and feeling nothing is not evidence of an inactive preparation.
I would rather say I do not know than round it up to an answer.
Adding the boring version of taste changes and food aversion, because the interesting version keeps getting posted and the boring one is usually right.
Check the ordinary explanations, in order, and stop when one of them accounts for what you are seeing. Most of the time the second one does.
Following this. I have the same question and no better information than the first post.
Reported effects on taste and on food preference are common and interesting and unstudied in any detail. They are also the ones people find most disconcerting.
This follows post #21 rather than contradicting it.
A definition problem is doing most of the work in this taste changes and food aversion discussion. Once the term is pinned down I suspect the disagreement mostly goes away and what is left is small.
Worth separating two things that post #20 runs together.
What I would check first on taste changes and food aversion is whether the thing being measured moved or whether the way of measuring it moved. Those look identical in a graph.
Fatigue: commonly reported, frequently multifactorial. It is worth asking whether other factors have changed (sleep, training volume, diet adequacy, hydration) before attributing all of it to the compound. Some fatigue resolves with time; some persists.
Taste changes and food aversion was covered in the wiki last year and the page has a review date on it, which is a better starting point than my memory of a thread.
Post #24 and I disagree about the size of the effect, not about the direction.
Reading this taste changes and food aversion thread as someone who came in with a fixed view: the third and seventh replies moved me and the confident ones did not.
Narrowing post #26, because the general version has more than one answer.
Taste changes and food aversion has a well-known answer and a correct answer, and the interesting work is establishing that they are the same. Nobody has done that here yet.